Home > Financial Ratios > NEULAND LABORATORIES

NEULAND LABORATORIES
EV/EBIT

    Back to All Ratios
NEULAND LABORATORIES is part of below Screeners ↓
Top Small Cap Stocks with Best Fundamentals
AD     Remove this Ad

NEULAND LABORATORIES Last 5 Year EV/EBIT History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   EV/EBIT(x) 43.3519.3210.3615.9722.96

What is the latest EV/EBIT ratio of NEULAND LABORATORIES ?

The latest EV/EBIT ratio of NEULAND LABORATORIES is 43.35 based on Mar2025 Consolidated results.
Year EV/EBIT
Mar202543.35
Mar202419.32
Mar202310.36
Mar202215.97
Mar202122.96

How is EV/EBIT of NEULAND LABORATORIES Trending?

Years EV/EBIT % Change
Mar2025 43.35
124.38
Mar2024 19.32
86.49
Mar2023 10.36
-35.13
Mar2022 15.97
-30.44
Mar2021 22.96 -

Other Financial Ratios of NEULAND LABORATORIES


Compare EV/EBIT ratio of peers of NEULAND LABORATORIES

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
NEULAND LABORATORIES ₹16,392.7 Cr -6.2% -3.3% 20.1% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹417,028.0 Cr 0.3% 9% 8.6% Stock Analytics
DIVIS LABORATORIES ₹170,237.0 Cr 1.9% 5.9% 12.6% Stock Analytics
TORRENT PHARMACEUTICALS ₹146,801.0 Cr 0.6% 9.5% 45% Stock Analytics
CIPLA ₹108,861.0 Cr 1.6% 1.8% -7.9% Stock Analytics
DR REDDYS LABORATORIES ₹107,435.0 Cr -1.5% 5.7% 14.5% Stock Analytics


NEULAND LABORATORIES Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
NEULAND LABORATORIES

-6.2%

-3.3%

20.1%

SENSEX

-1.8%

-1.6%

7.3%


You may also like the below Video Courses